General news
New Study Highlights BulbiCAM’s Potential in Parkinson’s Disease Monitoring
A newly published study in the Journal of Parkinson's Disease shows that BulbiCAM can detect measurable differences in pupillary responses in individuals with Parkinson's disease, supporting its potential as an objective tool for disease monitoring.Image of a peer-reviewed publication.
New Clinical Study Validates Dynamic Pupillary Responses as Functional Biomarkers for Age-Related Macular Degeneration (AMD)
Image of a peer-reviewed publication.
Karolinska Institutet joins as clinical partner with focus on patients with AMD & geographic atrophy
Karolinska Institutet joins as clinical partner with focus on patients with AMD & geographic atrophy
Eye Clinic Erzgebirge partners with Bulbitech
Eye Clinic Erzgebirge partners with Bulbitech
Neurologist Solveig E. J. Dalbro publishes first research article using BulbiCAM
Neurologist Solveig E. J. Dalbro publishes first research article using BulbiCAM
Alexander Sverstad, MD reveals in lecture that Eye Movement Perimetry is capable of distinghuishing healthy individuals from those with mild to moderate glaucoma as effectively as SAP
Alexander Sverstad, MD reveals in lecture that Eye Movement Perimetry is capable of distinghuishing healthy individuals from those with mild to moderate glaucoma as effectively as Standard Automated Perimety (SAP)
CHU Brugmann and Bulbitech join forces in diagnosing neuro-ophthalmological and neuro-vestibular disorders
CHU Brugmann and Bulbitech join forces in diagnosing neuro-ophthalmological and neuro-vestibular disorders
Rotschild Foundation Hospital and Bulbitech to collaborate on early biomarkers for AMD in NOGA1 study
Rotschild Foundation Hospital and Bulbitech to collaborate on early biomarkers for AMD in NOGA1 study
Pilot study Institut Català de Retina evaluates BulbiCAM as a promising tool to classify glaucoma from normal eyes due to significant correlation with other functional and structural tests.
Pilot study Institut Català de Retina evaluates BulbiCAM as a promising tool to classify glaucoma from normal eyes due to significant correlation with other functional and structural tests.
